Image Source: monitoringmedicines.org |
We have been seeing these ads for so long, hearing them
quietly spiel what seems to be a never-ending list of side effects then
subsequently prompt us to talk to our doctor today, that we have become accustomed
to them. However, in many countries this
is NOT the norm. The U.S. and New
Zealand are the only countries in the world that allow direct-to-consumer (DTC)
advertising of prescription medications.
Here in the U.S, however, this trend may soon be coming to an end.
The American Medical Association (AMA),
a professional organization of Doctors, has proposed a ban to DTC advertising
of prescription drugs. In a statement
released on November 17th 2015, AMA’s Board Chair-elect Dr. Patrice
A. Harris stated that the ban “…reflects concerns among physicians about the
negative impact of commercially-driven promotions, and the role that marketing
costs play in fueling escalating drug prices”.
DTC advertising, he continued, also “… inflates demand for new and more
expensive drugs, even when these drugs may not be appropriate.”
The AMA argues that prescription drug
advertisements often lead patients to choose brand name medication over generic
alternatives which are more economically efficient and just as clinically
effective. In addition, they cite data
released by health research company Altarum Institute to demonstrate the high
cost of medications. In 2015, for
example, prices for generic and brand name prescription drugs increased by 4.7
percent.
Although, it is no secret that the cost
of medications has been raising over the years, the problems with DTC may not
be just about cost. Many physicians identify
patient misinformation as a problem as well.
One study found that 57 percent, or roughly 6 out of ten prescription
drug advertisements contain misleading information. Many ads have been found to exaggerate
positive outcomes or leave out important information.
As you may imagine, pharmaceutical companies
are NOT happy about the proposal. Considering that pharmaceutical ads are a
major source of their revenue, neither are print magazines nor television
companies. Pharmaceutical companies have
spent a reported $4.5 billion in prescription drug advertisement in 2014, up 18
percent from the previous year. In a
statement released on November 19th, 2015, the Association of National Advertisers (ANA), which is also not pleased with the motion, stated
that the ban is not only a bad idea, but also one that “…raises very serious
First Amendment concerns”.
For the time being, however, all of
those opposed can rest easy. The AMA has
no actual power to ban DTC ads; only congress can make that decision. So far, no such determination by congress has
been made.
Originally published in LatinTrends Magazine, Mar 2016